Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Bibliografske podrobnosti
Main Authors:	Lowenberg, E, Cohen, S, van den Born, B, Meijers, J, Levi, M, Dondorp, A
Format:	Conference item
Izdano:	2008

Podobne knjige/članki

Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
od: Löwenberg, E, et al.
Izdano: (2010)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
od: Birnie, E, et al.
Izdano: (2017)

The von Willebrand factor – ADAMTS‐13 axis in malaria
od: Andrew S. O’Donnell, et al.
Izdano: (2022-01-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
od: Stefano Lancellotti, et al.
Izdano: (2013-09-01)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
od: Emma Birnie, et al.
Izdano: (2017-03-01)

Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease.
od: Zuben E Sauna, et al.
Izdano: (2009-08-01)

Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory
od: J-D Studt, et al.
Izdano: (2003-06-01)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
od: Emma Birnie, et al.
Izdano: (2020-09-01)

Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13
od: Shobhit Gogia, et al.
Izdano: (2017-10-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES-rev1-MJHID-2013
od: Raimondo De Cristofaro
Izdano: (2014-08-01)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
od: Gurbey Ocak, et al.
Izdano: (2021-06-01)

Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor
od: Clemens L. Bockmeyer, et al.
Izdano: (2008-01-01)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
od: Benjamin Reardon, et al.
Izdano: (2021-09-01)

Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
od: Deirdre Larkin, et al.
Izdano: (2009-03-01)

Von Willebrand Factor and ADAMTS13 in COVID-19 and Beyond: A Question of Balance
od: Emmanuel J Favaloro, et al.
Izdano: (2021-07-01)

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
od: E. V. Slukhanchuk, et al.
Izdano: (2023-01-01)

Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study
od: Taleen A MacArthur, et al.
Izdano: (2021-12-01)

An association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13
od: James Anthony Davies, et al.
Izdano: (2007-02-01)

Histone-induced thrombotic thrombocytopenic purpura in adamts13−/− zebrafish depends on von Willebrand factor
od: Liang Zheng, et al.
Izdano: (2020-04-01)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
od: Abdulla Ahmed, et al.
Izdano: (2021-10-01)

The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis
od: Stefano Lancellotti, et al.
Izdano: (2022-04-01)

Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.
od: Kanwal Singh, et al.
Izdano: (2021-01-01)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
od: Waldemar E. Wysokinski, MD, PhD, et al.
Izdano: (2021-03-01)

Comparative assessment of changes ADAMTS-13/von Willebrand factor axis in singleton and bichorial biamniotic pregnancy
od: F. Е. Yagubova, et al.
Izdano: (2024-09-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
od: K. N. Grigoreva, et al.
Izdano: (2021-03-01)

Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women
od: N. R. Gashimova, et al.
Izdano: (2023-03-01)

Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome
od: Yoko Yoshida, et al.
Izdano: (2017-09-01)

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study
od: Hanna L. Obermeier, et al.
Izdano: (2019-07-01)

The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting
od: Giovanni Tiscia, et al.
Izdano: (2021-09-01)

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy
od: Shinya Yamada, et al.
Izdano: (2024-07-01)

Imbalance of the von Willebrand Factor — ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)
od: Max Braune, et al.
Izdano: (2024-06-01)

Transforming the major autoantibody site on ADAMTS13: spacer domain variants retaining von Willebrand factor cleavage activity
od: Marie Scully
Izdano: (2020-11-01)

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease
od: Julien Demagny, et al.
Izdano: (2021-01-01)

Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery
od: Katja Susanne Häußler MD, et al.
Izdano: (2020-10-01)

Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
od: Caroline Pereira Domingueti, et al.
Izdano: (2015-01-01)

The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure
od: Hiroaki Takaya, et al.
Izdano: (2023-01-01)

A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
od: Jingyu Zhang, et al.
Izdano: (2011-01-01)

Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13
Izdano: (2011-01-01)

Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13.
od: Jingyu Zhang, et al.
Izdano: (2011-01-01)

Regulation of ADAMTS Proteases
od: Keron W. J. Rose, et al.
Izdano: (2021-06-01)